Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV and Oral Ganciclovir for CMV Reactivation After Bone Marrow Transplant
NCT00530218Phase 2Completed
- Sponsor
- City of Hope
- Start
- Mar 1999
- Primary completion
- Feb 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of ganciclovir in cytomegalovirus infection (CMV), sponsored by City of Hope. Started Mar 1999; status: completed.
02
Drugs
ganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00530218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00530218.